Neuroprotective effects of cystamine in aged parkinsonian mice
- 30 June 2006
- journal article
- research article
- Published by Elsevier BV in Neurobiology of Aging
- Vol. 27 (6), 862-870
- https://doi.org/10.1016/j.neurobiolaging.2005.04.004
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Rotenone induces non‐specific central nervous system and systemic toxicityThe FASEB Journal, 2004
- Cystamine inhibits transglutaminase and caspase‐3 cleavage in glutamate‐exposed astroglial cellsJournal of Neuroscience Research, 2003
- Reduced Nurrl Expression Increases the Vulnerability of Mesencephalic Dopamine Neurons to MPTP‐Induced InjuryJournal of Neurochemistry, 1999
- Roads to neuralness: Embryonic neural induction as derepression of a default stateCell, 1994
- Pharmacodynamic Interactions Between Phenytoin and ValproateClinical Neuropharmacology, 1994
- Oxidative Stress, Glutamate, and Neurodegenerative DisordersScience, 1993
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- A catalyst function for MPTP in superoxide formationBiochemical and Biophysical Research Communications, 1985
- Glutathione peroxidase activity in Parkinson's disease brainNeuroscience Letters, 1985
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984